- Home
- ITOS vs IAUX Comparison
ITOS vs IAUX Comparison
Compare ITOS & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- IAUX
- Stock Information
- Founded
- ITOS 2011
- IAUX 2020
- Country
- ITOS United States
- IAUX United States
- Employees
- ITOS N/A
- IAUX N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- IAUX
- Sector
- ITOS Health Care
- IAUX
- Exchange
- ITOS Nasdaq
- IAUX Nasdaq
- Market Cap
- ITOS 446.6M
- IAUX 507.4M
- IPO Year
- ITOS 2020
- IAUX N/A
- Fundamental
- Price
- ITOS $10.11
- IAUX $0.70
- Analyst Decision
- ITOS Hold
- IAUX Buy
- Analyst Count
- ITOS 6
- IAUX 1
- Target Price
- ITOS $10.40
- IAUX $1.50
- AVG Volume (30 Days)
- ITOS 1.6M
- IAUX 4.4M
- Earning Date
- ITOS 08-06-2025
- IAUX 08-13-2025
- Dividend Yield
- ITOS N/A
- IAUX N/A
- EPS Growth
- ITOS N/A
- IAUX N/A
- EPS
- ITOS N/A
- IAUX N/A
- Revenue
- ITOS N/A
- IAUX $76,622,000.00
- Revenue This Year
- ITOS N/A
- IAUX $73.07
- Revenue Next Year
- ITOS N/A
- IAUX $101.03
- P/E Ratio
- ITOS N/A
- IAUX N/A
- Revenue Growth
- ITOS 177.89
- IAUX 40.21
- 52 Week Low
- ITOS $4.80
- IAUX $0.34
- 52 Week High
- ITOS $18.13
- IAUX $1.26
- Technical
- Relative Strength Index (RSI)
- ITOS 53.14
- IAUX 66.05
- Support Level
- ITOS $10.08
- IAUX $0.57
- Resistance Level
- ITOS $10.17
- IAUX $0.62
- Average True Range (ATR)
- ITOS 0.04
- IAUX 0.03
- MACD
- ITOS -0.02
- IAUX 0.01
- Stochastic Oscillator
- ITOS 35.29
- IAUX 92.41
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.